Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06954103

Mechanisms And Prognosis of Stroke-Heart Syndrome

Status
Recruiting
Phase
Study type
Observational
Enrollment
658 (estimated)
Sponsor
Chensheng Pan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The incidence of stroke-heart syndrome following acute stroke, which encompasses both acute ischemic stroke and acute intracerebral hemorrhage, is notably high and is strongly associated with increased mortality and poor outcomes in stroke patients. However, the underlying mechanisms remain unclear, and there are currently no effective prevention or treatment strategies. This study aims to elucidate the neuro-humoral mechanisms of stroke-heart syndrome through multimodal imaging and multi-omics blood analysis. Additionally, it seeks to observe the progression of stroke-heart syndrome and its impact on functional outcomes, cognitive abilities, and emotional issues post-stroke. The research is expected to uncover novel blood biomarkers and brain network mechanisms associated with stroke-heart syndrome, providing potential targets and theoretical foundations for pharmacological treatments or physical interventions. Furthermore, it aims to establish a risk early-warning system for major cardiovascular complications post-stroke, enabling early identification, early intervention, and integrated brain-heart management to improve clinical outcomes for stroke patients.

Conditions

Timeline

Start date
2025-03-01
Primary completion
2028-03-01
Completion
2028-04-01
First posted
2025-05-01
Last updated
2025-05-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06954103. Inclusion in this directory is not an endorsement.